Literature DB >> 10807601

Depression in Parkinson's disease.

H Allain, S Schuck, N Mauduit.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10807601      PMCID： PMC1127292          DOI： 10.1136/bmj.320.7245.1287

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  12 in total

1.  Transient acute depression induced by high-frequency deep-brain stimulation.

Authors:  B P Bejjani; P Damier; I Arnulf; L Thivard; A M Bonnet; D Dormont; P Cornu; B Pidoux; Y Samson; Y Agid
Journal:  N Engl J Med       Date:  1999-05-13       Impact factor: 91.245

2.  Psychiatric symptoms in Parkinsonism.

Authors:  R H Mindham
Journal:  J Neurol Neurosurg Psychiatry       Date:  1970-04       Impact factor: 10.154

3.  Is it safe to combine a selective serotonin reuptake inhibitor with selegiline?

Authors:  S C Toyama; R P Iacono
Journal:  Ann Pharmacother       Date:  1994-03       Impact factor: 3.154

4.  Effect of age at onset on frequency of depression in Parkinson's disease.

Authors:  V S Kostíc; S R Filipović; D Lecić; D Momcilović; D Sokić; N Sternić
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-10       Impact factor: 10.154

Review 5.  Depression in patients with Parkinson's disease.

Authors:  J L Cummings; D L Masterman
Journal:  Int J Geriatr Psychiatry       Date:  1999-09       Impact factor: 3.485

6.  The frequency and associated risk factors for dementia in patients with Parkinson's disease.

Authors:  K Marder; M X Tang; L Cote; Y Stern; R Mayeux
Journal:  Arch Neurol       Date:  1995-07

7.  An estimate of the incidence of depression in idiopathic Parkinson's disease.

Authors:  G Dooneief; E Mirabello; K Bell; K Marder; Y Stern; R Mayeux
Journal:  Arch Neurol       Date:  1992-03

8.  Parkinson's disease and depression. A critical re-evaluation.

Authors:  A E Taylor; J A Saint-Cyr; A E Lang; F T Kenny
Journal:  Brain       Date:  1986-04       Impact factor: 13.501

9.  Preliminary examination of the comorbidity of anxiety and depression in Parkinson's disease.

Authors:  R Henderson; R Kurlan; J M Kersun; P Como
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1992       Impact factor: 2.198

10.  Does fluoxetine exacerbate Parkinson's disease?

Authors:  C F Caley; J H Friedman
Journal:  J Clin Psychiatry       Date:  1992-08       Impact factor: 4.384
View more
  16 in total

Review 1.  Neuropsychiatry of the basal ganglia.

Authors:  H A Ring; J Serra-Mestres
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-01       Impact factor: 10.154

Review 2.  Neuropsychiatric non-motor aspects of Parkinson's disease.

Authors:  B R Thanvi; S K Munshi; N Vijaykumar; T C N Lo
Journal:  Postgrad Med J       Date:  2003-10       Impact factor: 2.401

Review 3.  Parkinson's disease: the quintessential neuropsychiatric disorder.

Authors:  Daniel Weintraub; David J Burn
Journal:  Mov Disord       Date:  2011-05       Impact factor: 10.338

4.  Depression Comorbid With Stroke, Traumatic Brain Injury, Parkinson's Disease, and Multiple Sclerosis: Diagnosis and Treatment.

Authors:  Susan K Conroy; Katherine B Brownlowe; Thomas W McAllister
Journal:  Focus (Am Psychiatr Publ)       Date:  2020-04-23

5.  Effectiveness of Electroconvulsive Therapy (ECT) in Parkinsonian Symptoms: A Case Series.

Authors:  Sandeep Grover; Aditya Somani; Neeru Sahni; Sahil Mehta; Swati Choudhary; Rahul Kumar Chakravarty; Anju Moni Rabha
Journal:  Innov Clin Neurosci       Date:  2018-02-01

6.  Adenosine A2A receptor antagonists are potential antidepressants: evidence based on pharmacology and A2A receptor knockout mice.

Authors:  M El Yacoubi; C Ledent; M Parmentier; R Bertorelli; E Ongini; J Costentin; J M Vaugeois
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

Review 7.  Parkinson's disease.

Authors:  Timothy R Mhyre; James T Boyd; Robert W Hamill; Kathleen A Maguire-Zeiss
Journal:  Subcell Biochem       Date:  2012

8.  Desipramine induced changes in the norepinephrine transporter, alpha- and gamma-synuclein in the hippocampus, amygdala and striatum.

Authors:  Alexis M Jeannotte; John G McCarthy; Anita Sidhu
Journal:  Neurosci Lett       Date:  2009-10-08       Impact factor: 3.046

Review 9.  Management of psychiatric disorders in Parkinson's disease : Neurotherapeutics - Movement Disorders Therapeutics.

Authors:  Daniel Weintraub
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 7.620

Review 10.  CBT for the treatment of depression in Parkinson's disease: a promising nonpharmacological approach.

Authors:  Roseanne DeFronzo Dobkin; Matthew Menza; Karina L Bienfait
Journal:  Expert Rev Neurother       Date:  2008-01       Impact factor: 4.618
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.